GlassScriptPhysician profile
Leslie M Denton
NPI 1548385594
$2,282.38
in general payments reported to CMS, 2019-2025
20 companies · $46.46 in 2025
The $46.46 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $89.08 · 2021: $472 · 2022: $372 · 2023: $1,038 · 2024: $110 · 2025: $46.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $693.76 | 2019-2023 | Tepezza, Krystexxa |
| Melinta Therapeutics, LLC | $442.37 | 2021-2025 | Kimyrsa, Rezzayo |
| Lucid Diagnostics INC. | $191.37 | 2023 | |
| Amgen INC. | $128.93 | 2020-2023 | Evenity, Prolia |
| Viiv Healthcare Company | $124.84 | 2023 | Dovato |
| Eisai INC. | $120.37 | 2023 | |
| Genentech USA, INC. | $112.12 | 2021 | |
| Grifols USA, LLC | $88.05 | 2020-2023 | Gamunex-C |
| Astrazeneca Pharmaceuticals LP | $76.61 | 2022-2023 | Fasenra |
| Daiichi Sankyo INC. | $68.61 | 2021-2022 | |
| Allergan, INC. | $50.50 | 2019-2020 | |
| Tersera Therapeutics LLC | $30.22 | 2023 | Quzyttir |
| Pharmacosmos Therapeutics INC. | $25.80 | 2023 | Monoferric |
| Abbvie INC. | $23.80 | 2024 | |
| Amag Pharmaceuticals, INC. | $21.63 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $20.48 | 2021 | |
| Argenx US, INC. | $18.59 | 2023 | Vyvgart |
| Ani Pharmaceuticals, INC. | $18.12 | 2023 | Purified Cortrophin Gel |
| Glaxosmithkline, LLC. | $14.18 | 2022 | |
| Janssen Biotech, INC. | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.